Literature DB >> 19869781

SPECIFIC PRECIPITATION AND MOUSE PROTECTION IN TYPE I ANTIPNEUMOCOCCUS SERA.

M Heidelberger1, R H Sia, F E Kendall.   

Abstract

1. A rapid and simple method is given for the approximate determination of the specifically precipitable protein in Type I antipneumococcus sera. 2. It is shown that a close parallel exists between the specifically precipitable protein and the number of mouse protection units in a wide variety of Type I antipneumococcus sera. 3. Owing to the consistent results obtained and the rapidity, simplicity, and economy of the method, its use is proposed instead of the mouse protection test as a basis for the titration of standard sera and the comparison of others with a standard. 4. A method is given for conveniently preparing highly purified specific polysaccharide of Type I pneumococcus.

Entities:  

Year:  1930        PMID: 19869781      PMCID: PMC2131887          DOI: 10.1084/jem.52.4.477

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  CONCENTRATION OF THE PROTECTIVE BODIES IN ANTIPNEUMOCOCCUS SERUM BY MEANS OF SPECIFIC PRECIPITATION.

Authors:  F P Gay; H T Chickering
Journal:  J Exp Med       Date:  1915-04-01       Impact factor: 14.307

2.  THE STANDARDIZATION OF ANTIPNEUMOCOCCIC SERUM TYPES I AND II.

Authors:  J Zozaya; J Boyer; J Clark
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

3.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : THIRD PAPER.

Authors:  M Heidelberger; W F Goebel; O T Avery
Journal:  J Exp Med       Date:  1925-10-31       Impact factor: 14.307

4.  A QUANTITATIVE STUDY OF THE PRECIPITIN REACTION BETWEEN TYPE III PNEUMOCOCCUS POLYSACCHARIDE AND PURIFIED HOMOLOGOUS ANTIBODY.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1929-11-30       Impact factor: 14.307

  4 in total
  25 in total

1.  The persistence in mice of certain foreign proteins and azoprotein tracer-antigens derived from them.

Authors:  P D McMASTER; H KRUSE
Journal:  J Exp Med       Date:  1951-10       Impact factor: 14.307

2.  Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types.

Authors:  S C Szu; S Clarke; J B Robbins
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

3.  THE STANDARDIZATION OF ANTIPNEUMOCOCCIC SERUM TYPES I AND II.

Authors:  J Zozaya; J Boyer; J Clark
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

4.  QUANTITATIVE STUDIES ON ANTIBODY PURIFICATION : II. THE DISSOCIATION OF ANTIBODY FROM PNEUMOCOCCUS SPECIFIC PRECIPITATES AND SPECIFICALLY AGGLUTINATED PNEUMOCOCCI.

Authors:  M Heidelberger; E A Kabat
Journal:  J Exp Med       Date:  1938-01-31       Impact factor: 14.307

5.  CHEMICAL STUDIES ON BACTERIAL AGGLUTINATION : II. THE IDENTITY OF PRECIPITIN AND AGGLUTININ.

Authors:  M Heidelberger; E A Kabat
Journal:  J Exp Med       Date:  1936-04-30       Impact factor: 14.307

6.  QUANTITATIVE STUDIES ON THE PRECIPITIN REACTION : THE DETERMINATION OF SMALL AMOUNTS OF A SPECIFIC POLYSACCHARIDE.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1932-03-31       Impact factor: 14.307

7.  ACTIVE IMMUNIZATION OF MICE WITH THE POLYSACCHARIDES OF PNEUMOCOCCI TYPES I, II AND III.

Authors:  J Zozaya; J Clark
Journal:  J Exp Med       Date:  1933-01-01       Impact factor: 14.307

8.  QUANTITATIVE STUDIES ON ANTIBODY PURIFICATION : I. THE DISSOCIATION OF PRECIPITATES FORMED BY PNEUMOCOCCUS SPECIFIC POLYSACCHARIDES AND HOMOLOGOUS ANTIBODIES.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1936-07-31       Impact factor: 14.307

9.  STUDIES ON INFLUENZAL MENINGITIS : II. B. INFLUENZAE-THE PROBLEM OF VIRULENCE AND RESISTANCE.

Authors:  J Wright; H K Ward
Journal:  J Exp Med       Date:  1932-01-31       Impact factor: 14.307

10.  STUDIES ON MENINGOCOCCUS INFECTION : IX. STANDARDIZATION AND CONCENTRATION OF ANTIMENINGOCOCCUS HORSE SERUM (TYPE I).

Authors:  H W Scherp; G Rake
Journal:  J Exp Med       Date:  1936-03-31       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.